Drug
Rmc 4630
Rmc 4630: highest development phase Phase 2, developed by Revolution Medicines. 3 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Revolution Medicines
Trials
| Drug | Phase | Indication |
|---|---|---|
| RMC-4630 NCT05054725 | Phase 2 | Non-Small Cell Lung Cancer |
| RMC-4630 NCT03989115 | Phase 1/2 | Solid Tumor |
| RMC-4630 NCT03634982 | Phase 1 | Solid Tumors |
Latest
No recent events.
Follow Rmc 4630 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.